Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AVATAR-AF: Ablation vs Anti-arrhythmic Therapy for Atrial Fibrillation
NCT02459574Completed
- Sponsor
- Imperial College London
- Start
- May 2015
- Primary completion
- Sep 2018
- Countries
- 1
01
Overview
Randomised, open-label trial in Atrial fibrillation (AFib) (3 arms), sponsored by Imperial College London. Primary endpoint: All Hospital Episodes Related to Treatment for Atrial Arrhythmia at 12 months. Started May 2015; status: completed.
02
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT02459574.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02459574.